Winmill & Co’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-27,000
Closed -$1.27M – 111
2019
Q2
$1.27M Hold
27,000
– – 0.55% 77
2019
Q1
$1.3M Hold
27,000
– – 0.56% 82
2018
Q4
$1.2M Hold
27,000
– – 0.58% 83
2018
Q3
$1.46M Sell
27,000
-4,000
-13% -$205K 0.65% 76
2018
Q2
$1.51M Hold
31,000
– – 0.72% 70
2018
Q1
$1.94M Hold
31,000
– – 0.91% 59
2017
Q4
$1.9M Hold
31,000
– – 0.75% 67
2017
Q3
$2.08M Hold
31,000
– – 1.09% 37
2017
Q2
$2.42M Hold
31,000
– – 1.28% 24
2017
Q1
$2.53M Hold
31,000
– – 1.33% 17
2016
Q4
$2.23M Buy
+31,000
New +$2.24M 1.05% 30

Other funds holding CAH

Winmill & Co's CAH Position: Q3 2019 in Review

Winmill & Co sold out of Cardinal Health (CAH) in Q3 2019, closing a stake of 27,000 shares — an estimated $1.27M sold.

Winmill & Co first reported a position in CAH in Q4 2016 and held it in 11 quarters. The position peaked at $2.53M in Q1 2017. 663 funds tracked by Wall St. Rank hold CAH as of Q3 2019.

  • Winmill & Co reported no remaining Cardinal Health position as of Q3 2019 after selling out during the quarter.
  • Winmill & Co sold 27,000 Cardinal Health shares in Q3 2019, an estimated $1.27M.
  • Winmill & Co first reported a position in Cardinal Health in Q4 2016 and held it in 11 quarters.
  • Winmill & Co's Cardinal Health position peaked at $2.53M in Q1 2017.
  • 663 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2019.

Based on Winmill & Co's 13F filing for Q3 2019, filed 15 Oct 2019.